Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms

Next Generation Sequencing (NGS) in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes

NCT03058588 ·Status: RECRUITING

Prospective Study of Molecular Predictors of Survival in Myelodysplastic Syndromes

NCT02619565 ·Status: COMPLETED ·Phase: NA

Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms

NCT02084563 ·Status: COMPLETED ·Phase: PHASE2

Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome

NCT01311258 ·Status: RECRUITING

Prospective and Retrospective Observational Evaluation of Real World Outcome of Unfit AML Patients Treated With the Combination Venetoclax Plus Hypomethylating Agents, Under the Italian Law No.648/96

NCT04589728 ·Status: COMPLETED

Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care

NCT04212390 ·Status: COMPLETED

Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR

NCT02416388 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Prognostic Role of Minimal Residual Disease in Acute Myeloid Leukemia

NCT02714790 ·Status: COMPLETED

Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling, Multidrug Testing and MSC Interaction Studies

NCT05772559 ·Status: RECRUITING

Novel Drugs After Allo-HSCT in Patients With Multiple Myeloma

NCT04506320 ·Status: COMPLETED

GITMO AML/MDS-Relapse Registry Study

NCT06790680 ·Status: COMPLETED

Role of Adrenomedullin in Leukemic Endosteal/Vascular Niches

NCT04460963 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment)

NCT02085798 ·Status: COMPLETED

Registry on Hypomethylating Agents in Myeloid Neoplasms

NCT01595295 ·Status: COMPLETED

Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood

NCT00662090 ·Status: RECRUITING

Survival in Patients Older Than 60 Years With Newly Diagnosed AML in Spain

NCT03435341 ·Status: COMPLETED

Hypomethylating Agents and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Not Eligible for Intensive Chemotherapy

NCT04454580 ·Status: UNKNOWN

A Prospective, Multicentre European Registry for Newly Diagnosed Patients With Myelodysplastic Syndromes

NCT00600860 ·Status: UNKNOWN

Combination of HMA and Venetoclax With Posaconazole in Patients With Acute Myeloid Leukemia: A Study of Plasma Concentrations

NCT07254611 ·Status: COMPLETED

Treatment of Adult ALL With an MRD-directed Programme.

NCT00358072 ·Status: COMPLETED ·Phase: PHASE2

Study of Management and Prognosis of Patients With Acute Myeloblastic Leukemia in Saint-Antoine Hospital

NCT05558943 ·Status: NOT_YET_RECRUITING

Observational Study of Spatio-Temporal Patterns of New Cases of Acute Myeloid Leukemia

NCT03433521 ·Status: COMPLETED

NGS in AML Relapse

NCT03582241 ·Status: UNKNOWN

Observational Study on the Outcome of AML Patients Treated With New Drugs in Real-life (BoxTrial)

NCT06513273 ·Status: RECRUITING

Conventional and Experimental Chemotherapy With Allogeneic Transplant in Young Patients With Acute Myeloid Leukaemia

NCT01785953 ·Status: UNKNOWN